Multiple myeloma (MM) is a plasma B-cell malignancy that is characterized by the presence
of clonal proliferation of malignant plasma cells in the bone marrow, monoclonal protein in …

Conclusion In patients with heavily pretreated multiple myeloma obesity (BMI 30 or more)
was associated with better outcomes compared to BMI< 30. Response rate was similar in …

Obesity is a major public health problem throughout the world. It is defined as an excess
accumulation of adipose tissue, which is considered as a heterogeneous and highly active …

Obesity is a global pandemic that has been associated with the development of breast,
endometrial, large intestine, renal, esophageal, and pancreatic cancer. Obesity is also …

Despite tremendous advances in treatments for myeloma in the past decade, the disease
remains incurable in the majority of patients. Here, we review recent data demonstrating an …

Multiple myeloma (MM) remains an incurable plasma cell malignancy. Although little is
known about the etiology of MM, several metabolic risk factors such as obesity, diabetes …

Background Obesity is a risk factor for multiple myeloma (MM). However, we still lack
knowledge on the clinical course of obese MM patients in a broad view. Methods Here, we …

Obesity increases morbidity in and mortality of patients with various types of cancer.
However, the proportion of obese individuals in Asia is smaller than that in Western …

This article presents the first detailed overview of the mechanisms that may underlie the
relation of obesity with B-cell non-Hodgkin lymphomas (NHLs) and multiple myeloma (MM) …

An exploratory study was conducted of common clinical conditions as predictors of
subsequent cancer in 143,574 outpatients of a health maintenance organization (in …